Tongshu Gene
Tongshu Gene is a high-tech enterprise that focuses on the field of tumor precision medicine.
Funding reportedLast round: Series C
What company datasets say Tongshu Gene raised
Funding, as reported
Reported in all500Min the source's currency
Rounds1
Last roundSeries C
Last round dateJun 2021
Investors listed5
Genetics in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Tongshu Gene in front of investors. Or tell us what we have wrong.